Lenshil 4mg Capsule contains Lenvatinib, a targeted cancer medicine used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 10 Capsules in a Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Dasashil 70mg is a prescription cancer medicine that contains Dasatinib, a tyrosine kinase inhibitor (TKI), and it is primarily used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
